G. Dolan

3.4k citations

93 papers · 2.4k indexed · h-index 27

Impact in

Hematology top 0.5%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
- Hemostasis and retained surgical items
Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Hematology 74
- Hemophilia Treatment and Research 61
- Blood Coagulation and Thrombosis Mechanisms 31
- Platelet Disorders and Treatments 17
- Hemostasis and retained surgical items 12
- Chronic Myeloid Leukemia Treatments 7
Genetics 26
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7

Co-authors: Cédric Hermans (20 shared papers)Massimo Morfini (11 shared papers)Thierry Lambert (12 shared papers)Rolf Ljung (10 shared papers)Víctor Jiménez‐Yuste (13 shared papers)Gary Benson (10 shared papers)Brian O’Mahony (6 shared papers)Robert Klamroth (5 shared papers)
Journals: Haemophilia (32 papers)British Journal of Haematology (12 papers)European Journal Of Haematology (9 papers)Blood (3 papers)Thrombosis and Haemostasis (3 papers)
Partner nations: United Kingdom Germany Spain

In The Last Decade

G. Dolan

91 papers receiving 2.3k citations

Peers

Countries citing papers authored by G. Dolan

Since Specialization

Citations

This map shows the geographic impact of G. Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Dolan more than expected).

Fields of papers citing papers by G. Dolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Dolan. The network helps show where G. Dolan may publish in the future.

Co-authors

The 25 scholars most cited alongside G. Dolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Dolan Line = papers co-authored together G. Dolan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	European Study on Orthopaedic Status of haemophilia patients with inhibitors Haemophilia ·Massimo Morfini, Saturnino Haya, Giuseppe Tagariello, H. Pöllmann, Manuel Quintana, Britta Siegmund, Natalie Stieltjes, G. Dolan, J Tusell	2007	181
2	The Effect of a Monoclonal Antibody to Tumor Necrosis Factor on Survival from Childhood Cerebral Malaria The Journal of Infectious Diseases ·Michaël Boele van Hensbroek, Ayo Palmer, Emeka Onyiorah, G. Schneider, Shabbar Jaffar, G. Dolan, H. Memming, Joost Frenkel, G. Enwere, S.C.J. Bennett, Dominic Kwiatkowski, Brian Greenwood	1996	167
3	Changing patterns of bleeding in patients with severe haemophilia A Haemophilia ·David Stephensen, Robert C. Tait, N. Brodie, Peter W. Collins, R. CHEAL, David Keeling, Kristin Melton, G. Dolan, Heather Haye, E. HAYMAN, Mark Winter	2009	106
4	Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations Haemophilia ·Cédric Hermans, Carmen Altisent, Angelika Bátorová, Hérvè Chambost, Philippe de Moerloose, Anastasia Karafoulidou, Robert Klamroth, Michael Richards, Barry White, G. Dolan, (unknown)	2009	103
5	Achieving the unimaginable: Health equity in haemophilia Haemophilia ·Mark W. Skinner, Diane J. Nugent, Pam Wilton, Brian O’Mahony, G. Dolan, Jamie O’Hara, Erik Berntorp	2019	80
6	Practical aspects of extended half-life products for the treatment of haemophilia Therapeutic Advances in Hematology ·Thierry Lambert, Gary Benson, G. Dolan, Cédric Hermans, Víctor Jiménez‐Yuste, Rolf Ljung, Massimo Morfini, Silva Zupančić‐Šalek, Elena Santagostino	2018	80
7	Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients European Journal Of Haematology ·Rolf Ljung, G. Auerswald, Gary Benson, G. Dolan, Anne Duffy, Cédric Hermans, Víctor Jiménez‐Yuste, Thierry Lambert, Massimo Morfini, Silva Zupančić‐Šalek, Elena Santagostino	2018	77
8	Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis. PubMed ·Ian J. Williams, Adel Abuzenadah, Peter R. Winship, F E Preston, G. Dolan, Jonathan W. Wright, I R Peake, Anne Goodeve	1998	73
9	Pain and pain management in haemophilia Blood Coagulation & Fibrinolysis ·Günter Auerswald, G. Dolan, Anne Duffy, Cédric Hermans, Víctor Jiménez‐Yuste, Rolf Ljung, Massimo Morfini, Thierry Lambert, Silva Zupančić Šalek	2016	66
10	Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery Clinical Therapeutics ·Sorrel Wolowacz, Neil S. Roskell, Fiona Maciver, S Beard, Paul A. Robinson, Jonathan Plumb, G. Dolan, Ivan J. Brenkel	2009	61
11	Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis British Journal of Haematology ·J. T. Reilly, David Barnett, G. Dolan, Paul Forrest, J. M. Eastham, Alwyn Smith	1993	57
12	Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven^®] in elective orthopaedic surgery in haemophilic patients with inhibitors Haemophilia ·Paul Giangrande, J Wilde, B. Madan, C A Ludlam, Edward G. D. Tuddenham, N J Goddard, G. Dolan, J. Ingerslev	2009	55
13	Haemophilia care then, now and in the future Haemophilia ·Johannes Oldenburg, G. Dolan, G. Lemm	2008	55
14	Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data Haemophilia ·Michael Richards, Carmen Altisent, Angelika Bátorová, Hérvè Chambost, G. Dolan, Philippe de Moerloose, Máximo Fraga, Cédric Hermans, Anastasia Karafoulidou, Robert Klamroth, Riitta Lassila, C. Rothschild, (unknown)	2007	54
15	Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management. PubMed ·Gary Benson, Günter Auerswald, G. Dolan, Anne Duffy, Cédric Hermans, Rolf Ljung, Massimo Morfini, Silva Zupančić Šalek	2018	52
16	Protein C, antithrombin III and plasminogen: effect of age, sex and blood group British Journal of Haematology ·G. Dolan, Keith Neal, P. Cooper, Paula N. Brown, F. E. Preston	1994	49
17	The challenge of an ageing haemophilic population Haemophilia ·G. Dolan	2010	46
18	Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations Haemophilia ·Cédric Hermans, Philippe de Moerloose, Kathelijn Fischer, Katharina Holstein, Robert Klamroth, Thierry Lambert, Géraldine Lavigne-Lissalde, R.M. Álvarez Pérez, Michael Richards, G. Dolan, (unknown)	2011	45
19	The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders American Journal of Obstetrics and Gynecology ·Zoe E. Schaedel, G. Dolan, Martin C. Powell	2005	42
20	Efficacy of recombinant interferon‐alpha (rIFN‐α) in polycythaemia vera: a study of 17 patients and an analysis of published data British Journal of Haematology ·Peter C. Taylor, G. Dolan, J‐P. Ng, Beverley Paul, R. Collin, J. T. Reilly	1996	41

About G. Dolan

G. Dolan is a scholar working on Hematology, Genetics, Internal Medicine, Hepatology and Transplantation, having authored 93 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (61 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Platelet Disorders and Treatments (17 papers), Hemostasis and retained surgical items (12 papers), Cancer-related gene regulation (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (533 citations), Internal Medicine (157 citations), Public Health, Environmental and Occupational Health (218 citations) and Hepatology (50 citations). G. Dolan has collaborated with scholars based in United Kingdom, Germany and Spain. Frequent co-authors include Cédric Hermans, Massimo Morfini, Thierry Lambert, Rolf Ljung, Víctor Jiménez‐Yuste, Gary Benson, Brian O’Mahony, Robert Klamroth, Anne Duffy and Philippe de Moerloose. Their work appears in journals such as Haemophilia, British Journal of Haematology, European Journal Of Haematology, Blood and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact